fundsforNGOs

Innovations for Gram-Negative Antibiotic Discovery Challenge 2025

Innovations for Gram-Negative Antibiotic Discovery Challenge 2025

#image_title

Deadline: 25-Mar-25

The Novo Nordisk Foundation (NNF), Wellcome, and the Gates Foundation (GF) are jointly launching a new initiative, Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), to drive innovation in early drug discovery for Gram-negative pathogens.

This Grand Challenges RFP will identify and select the first projects within the consortium. The focus of this RFP will be on the discovery of antibiotics with broad spectrum activity against Enterobacteriaceae, using Klebsiella spp. as the pathogen to initiate a discovery program.

The Challenge 
Themes
Funding Information
Eligibility Criteria 
Ineligibility Criteria

For more information, visit Bill and Melinda Gates Foundation.

Exit mobile version